Trial intelligence / Profile preview

Modafinil in OEF/OIF Combat Veterans With PTSD

NCT01726088Phase 3Unknown

Sponsor
BRF
Start
Aug 2012
Primary completion
May 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Modafinil with Placebo (2 arms). Primary endpoint: Clinician Administered PTSD Scale at 4 weeks. Status: unknown.

02

Drugs

modafinil
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT01726088.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01726088.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call